Author

Dirk A. Wildemeersch

Observed names: D A A Wildemeersch, D Wildemeersch, D. A. Wildemeersch, D. WILDEMEERSCH, D. Wildemeersch, DIRK WILDEMEERSCH, Dirk A Wildemeersch, Dirk Wildemeersch, Dirk Wildemeersch,, Wildemeersch D, Wildemeersch D., Wildemeersch, Dirk

Institution: Flemish Government

Observed institutions: University of Debrecen, Stellenbosch University, Flemish Community, Flemish Government, Ghent University Hospital, Tygerberg Hospital, Ghent University, Haute École de Bruxelles, Zuyderland Medisch Centrum, Hôpital Saint-Louis, Tianjin Municipal Research Institute for Family Planning, Centre Hospitalier Universitaire de Saint-Pierre

ORCID: 0000-0001-9005-7665

Observed ORCID: 0000-0001-9005-7665

OpenAlex ID: A5071688419

Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: Long-term follow-up

2007 · D. Wildemeersch, D. Janssens, et al. · Maturitas · 97

Treatment of nonatypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system

2003 · D. Wildemeersch, M. Dhont · American Journal of Obstetrics and Gynecology · 93

Role of uterine forces in intrauterine device embedment, perforation, and expulsion

2014 · Norman Goldstuck, Dirk Wildemeersch · International Journal of Women s Health · 76

PDF

Performance of the frameless GyneFix and the TCu380A IUDs in a 3-year multicenter, randomized, comparative trial in parous women

2000 · Shangchun Wu, Jing Hu, et al. · Contraception · 61

Precision intrauterine contraception may significantly increase continuation of use: a review of long-term clinical experience with frameless copper-releasing intrauterine contraception devices

2013 · Dirk Wildemeersch, Ansgar Pett, et al. · International Journal of Women s Health · 48

PDF

Hysterectomy in six European countries

1983 · P.A. van Keep, D. Wildemeersch, et al. · Maturitas · 45

The effect on menstrual blood loss in women with uterine fibroids of a novel “frameless” intrauterine levonorgestrel-releasing drug delivery system: a pilot study

2002 · D. Wildemeersch, E. Schacht · European Journal of Obstetrics & Gynecology and Reproductive Biology · 44

COVID-19 contact tracing in Belgium: main indicators and performance, January – September 2021

2022 · Kristiaan Proesmans, Sharon Hancart, et al. · Archives of Public Health · 39

GyneFIX. The frameless intrauterine contraceptive implant--an update for interval, emergency and postabortal contraception.

1999 · D Wildemeersch, I Batár, et al. · PubMed · 36

A multicenter study assessing uterine cavity width in over 400 nulliparous women seeking IUD insertion using 2D and 3D sonography

2016 · Dirk Wildemeersch, Thomas Hasskamp, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 33

The frameless GyneFix® intrauterine implant: A major improvement in efficacy, expulsion and tolerance

1995 · H. van Kets, M. Vrijens, et al. · Advances in Contraception · 33

Assessment of menstrual blood loss in Brazilian users of the frameless copper-releasing IUD with copper surface area of 330 mm2 and the frameless levonorgestrel-releasing intrauterine system

2004 · A.T.L Andrade, J.P Souza, et al. · Contraception · 32

Performance and acceptability of intrauterine release of levonorgestrel with a miniature delivery system for hormonal substitution therapy, contraception and treatment in peri and postmenopausal women

2003 · D. Wildemeersch, E. Schacht, et al. · Maturitas · 32

Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study

2001 · D. Wildemeersch, E. Schacht · The European Journal of Contraception & Reproductive Health Care · 32

Three-year efficacy and acceptability of the GyneFix® 200 intrauterine system

2004 · Xiaoming Cao, Wenhao Zhang, et al. · Contraception · 31

Return to fertility in nulliparous and parous women after removal of the GyneFix® intrauterine contraceptive system

2002 · W. Delbarge, I. Bátár, et al. · The European Journal of Contraception & Reproductive Health Care · 31

Endometrial safety after 5 years of continuous combined transdermal estrogen and intrauterine levonorgestrel delivery for postmenopausal hormone substitution

2007 · D. Wildemeersch, K. Pylyser, et al. · Maturitas · 29

The ‘frameless’ intrauterine system for long‐term, reversible contraception: A review of 15 years of clinical experience

2003 · Dirk Wildemeersch, István Batár, et al. · Journal of obstetrics and gynaecology research · 29

Why perimenopausal women should consider to use a levonorgestrel intrauterine system

2016 · Dirk Wildemeersch · Gynecological Endocrinology · 28

Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems

2005 · Dirk Wildemeersch, Dirk Janssens, et al. · Contraception · 28

The Copper-Fix (Cu-Fix): a new concept in IUD technology

1988 · D. Wildemeersch, H. van der Pas, et al. · Advances in Contraception · 28

IUD expulsion solved with implant technology

1995 · H. Van Kets, D. Wildemeersch, et al. · Contraception · 27

Endometrial suppression with a new ‘frameless’ levonorgestrel releasing intrauterine system in perimenopausal and postmenopausal women: a pilot study

2000 · D Wildemeersch, E Schacht · Maturitas · 26

The GyneFix® implant systems for interval, postabortal and postpartum contraception: a significant advance in long-term reversible contraception

1997 · H. van Kets, H. Van der Pas, et al. · The European Journal of Contraception & Reproductive Health Care · 26

Use of frameless intrauterine devices and systems in young nulliparous and adolescent women: results of a multicenter study

2014 · Dirk Wildemeersch, Sohela Jandi, et al. · International Journal of Women s Health · 24

PDF

Works count: 145

Citation count: 1,770

H-index: 24

I10-index: 62